Literature DB >> 15950767

Quantitative analysis of tau isoform transcripts in sporadic tauopathies.

J W Connell1, T Rodriguez-Martin, G M Gibb, N M Kahn, A J Grierson, D P Hanger, T Revesz, P L Lantos, B H Anderton, J-M Gallo.   

Abstract

A number of neurodegenerative diseases, including Alzheimer's disease (AD), are characterized by intraneuronal accumulation of the tau protein. Some forms of FTDP-17 are caused by mutations in the tau gene affecting exon 10 splicing. Therefore, dysregulation of tau pre-mRNA splicing may be a contributing factor to sporadic tauopathies. To address this question, we devised a real-time RT-PCR strategy based on the use of a single fluorogenic probe to evaluate the ratio between tau isoforms containing or lacking exon 10 (4R/3R ratio) in post-mortem brain samples. We found a two- to six-fold increase in the 4R/3R ratio in cases of FTDP-17 linked to a splice site mutation, hence confirming the validity of the strategy. The difference in the 4R/3R ratio in the superior temporal and superior frontal gyri between AD and control brains was not statistically significant. Similarly, there was no significant difference in the 4R/3R ratio between Pick's disease cases and controls, indicating that the predominance of tau3R protein in PiD reflects post-translational modifications of specific isoforms. This study indicates that post-translational events are likely to be the main factors controlling tau isoform composition in sporadic tauopathies and highlights the benefit of quantitative RT-PCR in the assessment of splicing abnormalities in tauopathies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950767     DOI: 10.1016/j.molbrainres.2005.02.014

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  33 in total

1.  Quantification of type II procollagen splice forms using alternative transcript-qPCR (AT-qPCR).

Authors:  Audrey McAlinden; Kyu-Hwan Shim; Louisa Wirthlin; Soumya Ravindran; Thomas M Hering
Journal:  Matrix Biol       Date:  2012-09-10       Impact factor: 11.583

2.  Identification of Parkinson's disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson's disease patients.

Authors:  Rowena J Keyser; Ekow Oppon; Jonathan A Carr; Soraya Bardien
Journal:  J Neural Transm (Vienna)       Date:  2011-02-23       Impact factor: 3.575

3.  Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.

Authors:  Jianhua Shi; Wei Qian; Xiaomin Yin; Khalid Iqbal; Inge Grundke-Iqbal; Xiaosong Gu; Fei Ding; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

Review 4.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

5.  Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing.

Authors:  Teresa Rodriguez-Martin; Karen Anthony; Mariano A Garcia-Blanco; S Gary Mansfield; Brian H Anderton; Jean-Marc Gallo
Journal:  Hum Mol Genet       Date:  2009-06-04       Impact factor: 6.150

Review 6.  Tau-based treatment strategies in neurodegenerative diseases.

Authors:  Anja Schneider; Eckhard Mandelkow
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

Review 7.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

8.  Brain tau expression and correlation with the H1/H1 tau genotype in frontotemporal lobar degeneration patients.

Authors:  A Lladó; M Ezquerra; C Gaig; R Sánchez-Valle; E Tolosa; J L Molinuevo
Journal:  J Neural Transm (Vienna)       Date:  2007-07-30       Impact factor: 3.575

9.  Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

Authors:  J E Tobin; J C Latourelle; M F Lew; C Klein; O Suchowersky; H A Shill; L I Golbe; M H Mark; J H Growdon; G F Wooten; B A Racette; J S Perlmutter; R Watts; M Guttman; K B Baker; S Goldwurm; G Pezzoli; C Singer; M H Saint-Hilaire; A E Hendricks; S Williamson; M W Nagle; J B Wilk; T Massood; J M Laramie; A L DeStefano; I Litvan; G Nicholson; A Corbett; S Isaacson; D J Burn; P F Chinnery; P P Pramstaller; S Sherman; J Al-hinti; E Drasby; M Nance; A T Moller; K Ostergaard; R Roxburgh; B Snow; J T Slevin; F Cambi; J F Gusella; R H Myers
Journal:  Neurology       Date:  2008-05-28       Impact factor: 9.910

Review 10.  Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Authors:  Jianhua Zhou; Qingming Yu; Tie Zou
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.